eclipse treatment planning system version 8.6 (Varian Medical)
90
Structured Review
Varian Medical
eclipse treatment planning system version 8.6
Eclipse Treatment Planning System Version 8.6, supplied by Varian Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eclipse+treatment+planning+system+version+8%2E6/eclipsetm+treatment+planning+system/pm38263831-38-6-15
Average 90 stars, based on 1 article reviews
Eclipse Treatment Planning System Version 8.6, supplied by Varian Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eclipse+treatment+planning+system+version+8%2E6/eclipsetm+treatment+planning+system/pm38263831-38-6-15
Average 90 stars, based on 1 article reviews
eclipse treatment planning system version 8.6 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Evaluation of patient DVH‐based QA metrics for prostate VMAT: correlation between accuracy of estimated 3D patient dose and magnitude of MLC misalignment Article Snippet: Each plan was generated in Article Title: Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation Article Snippet: All treatment plans were reproduced using the Article Title: Dosiomics for intensity-modulated radiotherapy in patients with prostate cancer: survival analysis stratified by baseline prostate-specific antigen and Gleason grade group in a 2-institutional retrospective study. Article Snippet: All treatment plans were created by Article Title: Investigation of conformal and intensity-modulated radiation therapy techniques to determine the absorbed fetal dose in pregnant patients with breast cancer. Article Snippet: The aim of this research was to investigate the fetal doses of pregnant patients undergoing conformal radiotherapy or intensity-modulated radiation therapy (IMRT) for breast cancers.. An Alderson Rando phantom was chosen to simulate a pregnant patient with breast cancer who is receiving radiation therapy.. This phantom was irradiated using the Varian Clinac DBX 600 system (Varian Medical System, Palo Alto, CA) linear accelerator, according to the standard treatment plans of both three-dimensional conformal radiation therapy (3-D CRT) and IMRT techniques. Article Title: A comparison of volumetric modulated arc therapy and sliding-window intensity-modulated radiotherapy in the treatment of Stage I-II nasal natural killer/T-cell lymphoma. Article Snippet: This article is aimed to compare the dosimetric differences between volumetric modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) for Stage I-II nasal natural killer/T-cell lymphoma (NNKTL).. Ten patients with Stage I-II NNKTL treated with IMRT were replanned with VMAT (2 arcs).. The prescribed dose of the planning target volume (PTV) was 50 Gy in 25 fractions. Article Title: Radiomics of Patients with Locally Advanced Rectal Cancer: Effect of Preprocessing on Features Estimation from Computed Tomography Imaging Article Snippet: For each patient, the rectal gross tumor volume (GTV) was delineated (avoiding the inclusion of air regions) on CT images by a single experienced radiation oncologist, using the Article Title: Conformal orbit sparing radiation therapy: a treatment option for advanced skin cancer of the parotid and ear region Article Snippet: All plans were generated using the Varian Generated:Article Title: Optimizing treatment and analysis of prognostic factors for locally advanced nonsmall cell lung cancer in resource-limited population Article Snippet: BACKGROUND: Lung cancer most commonly presents in advanced stages in developing countries, where combined modality treatment using chemo‐radiotherapy (CTRT) is the standard of care.. MATERIALS AND METHODS: A retrospective audit of patients of nonsmall cell lung cancer (NSCLC) treated at a single Institute from January 2008 to December 2012 was conducted.. Various prognostic factors affecting disease‐free survival (DFS) and overall survival (OS) were studied by univariate and multivariate analysis. |